Meet us at the Anglonordic Life Science Conference in London. http://anglonordic.biopartnering.co.uk/
Charité BIH Entrepreneurship Summit Berlin, May 7 – 8, 2018
Sartar will pitch at the Life Sciences Venture Market 2018! http://www.stiftung-charite.de/en/events/charite-entrepreneurship-summit.html
The 2nd KYOTO−SPARK Symposium February 14, 2018.
Sartar will give a presentation at the 2nd KYOTO−SPARK Symposium.
http://www.kyoto-spark.med.kyoto-u.ac.jp/newsen/20171227161216/
Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation
The Vice-Chairman of the Board and a co-founder the Sartar Therapeutics Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation. Congratulations Heikki on your new appointment!
Sartar was awarded a U.S. patent 16.10.2017
Sartar was awarded a USA patent for use of anagrelide in cancer therapy.
